Q3 2023 · 13F-HR
M28 Capital Management LPholdings as filed
Filed 2023-11-13 · accession 0000902664-23-005476
$87.2M
Reported value
11
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $40.5M | 46.4% | 7,044,500 | Common | SOLE |
| 00534A102 | IVVD | INVIVYD INC | $15.7M | 18.0% | 9,248,250 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $10.7M | 12.3% | 523,280 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $4.6M | 5.24% | 197,700 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $3.6M | 4.10% | 363,800 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $3.2M | 3.67% | 121,200 | Common | SOLE |
| 231269309 | CRIS | CURIS INC | $2.8M | 3.19% | 421,951 | Common | SOLE |
| N71542109 | PRQR | PROQR THRAPEUTICS N V | $2.5M | 2.85% | 1,910,600 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $1.8M | 2.08% | 67,400 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $1.8M | 2.08% | 216,600 | Common | SOLE |
| 65344D109 | — | NEXIMMUNE INC | $28,009 | 0.03% | 133,442 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.